Newsroom

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating the fairness of the proposed Utz Brands, Inc. (NYSE: UTZ) (“Utz”) shareholder buyout to determine whether Utz shareholders may be able to obtain a higher price for their shares. Click here for additional information: https://kaskelalaw.com/case/utz-buyout/ On July 21, 2026, Utz announced that it had agreed to be acquired by European snack manufacturer Intersnack Group GmbH & Co. KG (“Intersnack”) at a price of $14.25 per share in c...

DENVER--(BUSINESS WIRE)--FirstSun Capital Bancorp (“FirstSun”) (NASDAQ: FSUN) reported net loss of $(22.9) million for the second quarter of 2026 compared to net income of $26.4 million for the second quarter of 2025. Earnings per diluted share were $(0.49) for the second quarter of 2026 compared to $0.93 for the second quarter of 2025. Adjusted net income, a non-GAAP financial measure, was $21.0 million or $0.45 per diluted share for the second quarter of 2026 compared to $26.6 million or $0.9...

OMAHA, Neb. & ATLANTA--(BUSINESS WIRE)--Union Pacific (NYSE: UNP) and Norfolk Southern (NYSE: NSC) today enhanced their merger application by offering customer protections that go beyond those provided in any prior rail merger. The new commitments are provided with the supplemental information requested by the Surface Transportation Board (STB) when it accepted the companies’ merger application as complete on May 28, 2026. “We are more confident than ever that creating America’s first transcont...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named One of the World’s Most Sustainable Companies by TIME for Third Consecutive Year...

ATLANTA--(BUSINESS WIRE)--The board of directors of Pinnacle Financial Partners, Inc. (NYSE: PNFP) approved the following dividends for holders of common and preferred stock: $0.50 per share on the firm’s common stock, payable on August 28, 2026, to shareholders of record as of August 7, 2026. $0.46579 per share on the firm’s Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series A, payable on September 21, 2026, to shareholders of record as of September 15, 2026. $0.52481 per...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Luxfer Holdings PLC (NYSE: LXFR) to affiliates of Wynnchurch Capital, L.P. for $17.37 per ordinary share in cash.Halper Sadeh encourages Luxfer shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Luxfer and its boar...

NEW YORK--(BUSINESS WIRE)--Link Logistics (“Link” or the “Company”), a leading operator of last-mile industrial real estate and warehouse properties, today announced the addition of a two-building industrial portfolio totaling 352,396 square feet in Texas' Dallas-Fort Worth and Austin metropolitan areas. The portfolio includes two infill industrial properties: a 291,285-square-foot warehouse property at 450 Airline Drive in Coppell, Texas, located within the DFW Airport submarket, and a 61,111-...

HOUSTON--(BUSINESS WIRE)--Ranger Energy Services, Inc. (NYSE: RNGR) (“Ranger” or the “Company”) today reported its financial and operational results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial and Operational Highlights Revenue of $176.5 million, compared to $159.1 million in the first quarter of 2026 and $140.6 million in the second quarter of 2025 Net income of $6.9 million, or $0.29 per diluted share, compared to $3.0 million, or $0.12 per diluted share, in the...

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conference(s): Management will host one-on-one investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 10, 2026. Management will present to investors at the 19th Annual Piper Sandler MedTech and Dia...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted three new employees options to purchase a total of 12,600 shares of the Company’s common stock at an exercise price per share of $29.73, which was...